Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (groß) | News | Bilanz/GuV | Dividende/HV | Zertifikate | Depot |
Times + Sales | Chart-Analyse | Analysen | Schätzungen | Termine | Optionsscheine | Watchlist |
Börsenplätze | Chartvergleich | Kursziele | Vergleich | Profil | Knock-Outs | Kaufen |
Orderbuch | Realtime Stuttgart | myNews | Insidertrades | Fonds | im Forum | |
Historisch | Realtime Push | Anleihen |
Freefloat | 87,63 % |
Größte Anteilseigner | in % |
---|---|
Shanghai Pharmaceuticals Holding Co., Ltd. | 7,18 |
Armistice Capital LLC | 2,67 |
Nantahala Capital Management LLC | 2,43 |
Joseph R. Hyde | 2,38 |
Invesco Dwa Healthcare Momentum Etf | 1,52 |
683 Capital Management LLC | 1,48 |
Hale BioPharma Ventures LLC | 1,19 |
Point72 Asset Management LP (Old) | 0,74 |
Eversept Partners LP | 0,70 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 27 | 21 | 14 | 14 | 26 |
Umsatz pro Mitarbeiter in Mio. USD | 0,00 | 0,00 | 0,17 | 0,24 | 0,17 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 46 | 31 | 21 | 118 | 93 |
Summe Anlagevermögen | 38 | 26 | 15 | 113 | 88 |
Summe Aktiva | 46 | 31 | 22 | 119 | 94 |
2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 0 | 0 | 0 | 0 | 0 |
Summe Fremdkapital | 8 | 5 | 7 | 6 | 5 |
Summe Eigenkapital | 38 | 26 | 14 | 113 | 88 |
Summe Passiva | 46 | 31 | 22 | 119 | 94 |
12230 El Camino Real, 92130 San Diego | |
Tel: | 1.858.434.1113 |
Fax: | 858.408.3010 |
Internet | http://www.oncternal.com |
Anita Wiseth Senior Vice President-Human Resources |
Charles P. Theuer Independent Director |
Chase C. Leavitt General Counsel |
Daniel L. Kisner Independent Director |
David F. Hale Chairman |
Gunnar F. Kaufmann Chief Scientific Officer |
James B. Breitmeyer President, Chief Executive Officer & Director |
Jinzhu Chen Independent Director |
Michael G. Carter Independent Director |
Pablo Urbaneja Senior Vice President-Corporate Development |
Rajesh Krishnan Chief Technology Officer |
Richard Glenn Vincent Chief Financial Officer, Secretary & Treasurer |
Robert James Wills Independent Director |
Rosemary Mazanet Independent Director |
Salim Yazji Chief Medical Officer |
Steven Hamburger Senior VP-Regulatory Affairs & Quality Assurance |
William R. LaRue Independent Director |
Xin Nakanishi Independent Director |
ETF-Sparplan